Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4 Other solid neoplasm 2 Breast 2 Tumor-Agnostic 1 Thoracic 1 Sarcoma 1 Other hematologic neoplasm 1 Gynecologic 1

Conditions

Ovarian Carcinosarcoma 1

Interventions

Doxorubicin 25 Cyclophosphamide 24 pembrolizumab 20 Specimen Handling 19 Temozolomide 16 Magnetic Resonance Spectroscopy 15 Surgical Procedures, Operative 14 Radiotherapy 13 Blood Specimen Collection 13 Biopsy 13 Gemcitabine 12 fludarabine 11 atezolizumab 11 Vincristine 11 Ifosfamide 11 X-Rays 8 Trabectedin 8 Nivolumab 8 Irinotecan 8 Imatinib Mesylate 8 Drug Therapy 8 cabozantinib 7 Surveys and Questionnaires 7 Radiation 7 liposomal doxorubicin 5 abemaciclib 5 Sunitinib 5 Standard of Care 5 Radiation Dose Hypofractionation 5 Dactinomycin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Antineoplastic Agents × Sarcoma × Clear all

NCT03651206 2026-06-01

ROCSAN

ARCAGY/ GINECO GROUP

Phase 2/3 Recruiting

GynecologicSarcoma

Ovarian Carcinosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡